Case 1 - Transcaval TAVR for AI

Dr. Devireddy is an Associate Professor of medicine of Interventional Cardiology at Emory University. He received his medical degree from the University of Michigan in 1998 and completed Internal Medicine training at Duke University in 2001. In 2005, he completed fellowship training in both Cardiovascular Medicine and Interventional Cardiology at Emory University. He proudly joined the faculty upon completion of fellowship. Dr. Devireddy's primary focus is on patient-centered and thoughtful care of those suffering from the effects of cardiovascular disease. As an interventional cardiologist with nearly 15 years of experience, he understands that all patients are unique and require customized care. He is comfortable addressing highly complex cases requiring advanced diagnostic intuition and technical precision that are referred from throughout the Southeast U.S. Dr. Devireddy actively participates in the Interventional Cardiology research department, which has substantially contributed to many groundbreaking clinical trials. His individual research interests include structural heart and valvular disease, minimally invasive therapies to lower blood pressure, and novel solutions for complex cardiovascular disease. His work has led to multiple publications in leading medical journals.

Dr. Gaetano Paone is a member of the Emory Structural Heart and Valve Center, where he focuses on valve repair and replacement, coronary artery bypass graft surgery (CABG), transcatheter aortic valve replacement (TAVR), and other related, less invasive valve technologies. Dr. Paone earned his MD at New York University School of Medicine, and completed his general surgery residency at New York University Medical Center. After completing his thoracic surgery residency at the University of Illinois Hospitals, he joined the cardiothoracic surgery faculty at Boston University Medical Center. In 1990, Dr. Paone joined Henry Ford Hospital in Detroit. Dr. Paone also practiced at Crittenton Hospital Medical Center in Rochester, MI, from 2004-2009, and obtained his Masters in Health Service Administration from the University of Michigan School of Public Health in 2006. In 2009, he returned to Henry Ford Hospital, where he served as chief of the Division of Cardiac Surgery for nine years.

George S. Hanzel, MD has joined Emory Healthcare and Emory University School of Medicine as an Associate Professor of Medicine. He is certified by the American Board of Internal Medicine in Cardiovascular Diseases and Interventional Cardiology. A graduate of Georgetown University School of Medicine in Washington, D.C., Dr. Hanzel completed his internship at the National Naval Medical Center in Bethesda, Maryland, his residency at Walter Reed Army Medical Center and then his cardiology fellowship at the National Naval Medical Center. Dr. Hanzel then served in the United States Navy, Lieutenant Commander, as a staff cardiologist at the Great Lakes Naval Hospital from 1999 to 2002. He completed an interventional cardiology fellowship in June 2004 at Beaumont Hospital in Royal Oak, Michigan. Dr. Hanzel then joined the Beaumont Hospital Royal Oak cardiology faculty in 2004 serving as Director of the Cardiac Catheterization Laboratory, Director of Structural Heart Disease, and associate professor at Oakland University William Beaumont School of Medicine until 2020. Dr. Hanzel's clinical and research interests include transcatheter aortic valve replacement, transcatheter therapies for mitral and tricuspid valve disease, alcohol septal ablation, and septal closure. Dr. Hanzel is a member of the STS/ACC Transcatheter Valve Therapy Registry Steering Committee and the Society for Cardiovascular Angiography and Interventions Structural Heart Disease Council.

Isida Byku, MD, FACC is an Assistant Professor of Medicine at Emory University, specializing in coronary and structural heart intervention. Dr. Byku also serves as the fellowship program director for the Structural Heart and Valve fellowship. After receiving her medical degree from Dartmouth Medical School, Dr. Byku completed residency training in internal medicine at the Johns Hopkins Hospital, followed by fellowship training in cardiovascular disease at the University of Chicago. She then came to Emory for a two-year fellowship in interventional cardiology and structural heart and valve disease, upon completion of which she joined as faculty. As a member of the cutting-edge structural team at Emory, Dr. Byku's areas of interest include advancements in the field of transcatheter therapies for structural heart and valve disease.

Dr. Jason Foerst is an Associate Professor in Cardiology at Virginia Tech-Carilion School of Medicine and Carilion Clinic in Roanoke, VA. He is a structural interventionalist with 12 years of experience in the field. He is actively participating in clinical trials for aortic stenosis, mitral regurgitation, paravalve leak repair, left atrial appendage closure and left ventricular remodeling

Specialties: Catheter-based interventional heart valve procedures (TAVI and TEER with clip systems). Structural cardiac interventions (atrial appendage occlusion/PFO occlusion/ASD occlusion/complex problem interventions).

Dr. Paul Mahoney is the Director of the Structural Heart and Complex High Risk Intervention Programs at Sentara Health, a 14 Hospital System in Virginia and North Carolina. He has extensive clinical experience in transcatheter aortic and mitral valve replacement, mitral edge to edge repair, and left atrial appendage closure. He leads the complex high risk PCI team at Sentara Health. Dr. Mahoney has served as local PI in many clinical research trials including PARTNER, SURTAVI, TRILLUMINATE, TRISCEND, REPAIR MR, SMART TRIAL, OPTIMIZE PRO, EXCEL, PORTICO, APOLLO, EARLY TAVR, EXCEED, EXPAND, SYNTAX, M3 and dozens of others.

Roger J. Laham, MD is a high-volume Interventional cardiologist and proliferative scientist. He performs coronary, peripheral, and structural interventions and is the Director of the Structural Heart Center at BIDMC/Harvard Medical School. He has had numerous contributions that advanced the field of Interventional cardiology and peripheral vascular disease. Dr. Laham’s research activities centered on translational research in vascular biology, angiogenesis, myogenesis, imaging and new device development. These efforts have taken the form of basic research projects focused on restenosis and the endothelial responses to angiogenic growth factors, animal research projects focused on physiologic assessment of coronary angiogenesis in porcine models of myocardial ischemia and murine models of acute myocardial infarction, drug delivery research, cell and stem-cell based therapy, myotissue transplantation, and clinical trials testing efficacy of angiogenic growth factors and new devices in patients with advanced coronary disease and congestive heart failure, and imaging of coronary disease (Multidetector CT), IVUS, and PET/CT for vulnerable plaque imaging, structural heart disease and percutaneous valves.

Dr Lederman is the chief of the Laboratory of Cardiovascular Intervention at the NHLBI Division of Intramural Research in Bethesda Maryland USA. His program creates new catheter treatments & devices for structural heart disease and introduces them into medical practice. His multidisciplinary team includes cardiologists, imaging physicists, and biomedical engineers. The NHLBI Lederman lab has created and translated into clinical practice several novel procedures including transcaval access to the aorta; mitral cerclage ventriculoplasty; LAMPOON, ELASTIC, and BASILICA leaflet modification to allow TMVR and TAVR; myocardial intramural navigation procedures including MIRTH ventriculoplasty, SESAME myotomy, and VINTAGE ablation; and MRI heart catheterization. These procedures and protocols are possible though a network of luminary collaborating structural heart interventional cardiologists.

Dr. Scott Chadderdon, M.D., is an Associate Professor of Medicine in the Division of Cardiovascular Medicine at the School of Medicine in Portland, Oregon. He specializes in cardiac imaging, general cardiology, heart disease and diabetes, and heart valve conditions. He practices at OHSU Hospital - Marquam Hill Campus and is board certified in cardiovascular disease.